Patents Assigned to Eye Care International, LLC
  • Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
    Patent number: 11534459
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: December 27, 2022
    Assignee: EYE CARE INTERNATIONAL, LLC
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
    Patent number: 11191781
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: December 7, 2021
    Assignee: Eye Care International, LLC
    Inventors: Matthew B. Dowling, Steven E. Lazar, Helga M. Gentile
  • COMPOSITIONS AND METHODS OF TREATING DRY EYE SYNDROME AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES
    Publication number: 20190175647
    Abstract: The present disclosure relates to a composition including non-autologous plasma or serum and a polymer; method of treating ophthalmic diseases (e.g., dry eye syndrome) or moisturizing and/or repairing non-keratinized surfaces including non-healing wounds with a composition including non-autologous plasma or serum and a polymer; and a therapeutic agent delivery device for delivery of the composition to the eye or a non-keratinized surface of a subject.
    Type: Application
    Filed: June 16, 2017
    Publication date: June 13, 2019
    Applicant: Eye Care International, LLC
    Inventors: Matthew B. DOWLING, Steven E. LAZAR, Helga M. GENTILE